MARCH 24TH, 2021 @ 3PM GMT
While most of the world shut down to reduce the spread of the SARS-CoV-2 virus, scientists, academics and industry leaders worked tirelessly to try to find solutions – medications and treatments that have helped those most severely affected, numerous vaccines in trial stages and others already with approval. “Wash your hands” reminders and hand sanitising stations at every turn are now commonplace.
Labskin understood that testing viruses to discover what products will reduce transmission via skin-to-skin and skin-to-surface contact would be challenging. Through a partnership with the University of Aberdeen, the Labskin R&D team has been working to develop a protocol for tests to prove the efficacy of soaps/sanitisers against Covid-19, and to develop an alternative to in-person Clinical Trials.
Join the team to examine the data from these studies and how the virus can be observed on Labskin’s HSE technology. Labskin’s Eric Clarke, Head of Sales, David Caballero-Lima, Head of R&D, and Nicola Kingswell, Services Manager discuss how this can assist in proving efficacy for Soaps, Hand Sanitisers and other Hygiene related products. There will be a presentation of the Protocol itself, followed by a run-through of the Labskin Remote Clinical Trials platform and how it can help in the fight against Covid.